Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by Law.com, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!

X

About the Author

Lisa Shuchman

Lisa Shuchman

Lisa Shuchman is a Senior reporter for Corporate Counsel and The AmLaw Litigation Daily. She covers all aspects of intellectual property law and is based in New York. She has lived and worked in Japan, has traveled extensively in Asia, Europe and other parts of the world. You can read more of her articles here and follow her on Twitter @LisaLawReporter.

Article List

  • Lawmakers Consider Taxing IP at a Lower Rate

    Politicians and the public were outraged when New York-based Pfizer announced its plan to merge with Dublin-based Allergan and move its headquarters to Ireland. Pfizer was accused of being “unpatriotic” and the move was called a “disgrace” and a “travesty.” But Pfizer said the move made sense. It would enable...

Advertisement. Closing in 15 seconds.